Guardant Health
GH
#1569
Rank
HK$103.08 B
Marketcap
HK$793.71
Share price
-5.99%
Change (1 day)
180.51%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of December 2025 (TTM): 14.7

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -37.4. At the end of 2025 the company had a P/S ratio of 8.29.

P/S ratio history for Guardant Health from 2018 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20258.2962.98%
20245.09-12.59%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Natera
NTRA
15.9 8.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
1.47-90.02%๐Ÿ‡บ๐Ÿ‡ธ USA